- Home
- HELE vs AVTX Comparison
HELE vs AVTX Comparison
Compare HELE & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HELE | AVTX |
|---|---|---|
| Founded | 1968 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.6M | 710.1M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HELE | AVTX |
|---|---|---|
| Price | $29.02 | $11.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | $31.67 | ★ $44.08 |
| AVG Volume (30 Days) | 534.3K | ★ 983.9K |
| Earning Date | 10-08-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $1,478,845,000.00 | $27,813,137.00 |
| Revenue This Year | $0.95 | N/A |
| Revenue Next Year | $1.50 | N/A |
| P/E Ratio | $17.47 | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $13.85 | $11.58 |
| 52 Week High | $31.98 | $24.27 |
Technical Indicators
Market Signals| Indicator | HELE | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.93 | 21.56 |
| Support Level | $24.96 | N/A |
| Resistance Level | $29.63 | $20.54 |
| Average True Range (ATR) | 1.84 | 0.78 |
| MACD | 0.30 | -0.19 |
| Stochastic Oscillator | 57.96 | 4.52 |
Price Performance
Historical ComparisonAbout HELE Helen of Troy Limited
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.